LifeLabs
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
$2.3m | Series A | ||
* | $985m Valuation: $985m | Acquisition | |
Total Funding | €2.1m |
Recent News about LifeLabs
EditLifeLabs is a Canadian-owned company that has been serving the healthcare needs of Canadians for more than 50 years. Specializing in diagnostic and genetic testing services, LifeLabs operates in the healthcare market, catering to individual patients, healthcare providers, hospitals, and long-term care facilities. The company completes over 2 million COVID-19 molecular tests and collaborates with organizations like TELUS Health and the Canadian Centre for Diversity and Inclusion to support better healthcare outcomes. LifeLabs generates revenue through its comprehensive range of laboratory services, including standard lab testing, genetic and naturopathic testing, and the development of new technologies. The business model focuses on providing essential diagnostic information that aids in the prevention, diagnosis, treatment, and management of diseases. LifeLabs also engages in community initiatives, such as donations to pediatric oncology and supporting diversity and inclusion efforts. The company has been recognized on Forbes' Best Employers list and continues to innovate in response to healthcare challenges.
Keywords: diagnostic testing, genetic testing, healthcare, COVID-19 testing, laboratory services, innovation, community engagement, TELUS Health, diversity, Canadian-owned.